higherthanexpected

By Patrick Wingrove (Reuters) – Moderna (NASDAQ:) reported a surprise third-quarter profit on Thursday, driven by cost cutting and higher-than-expected sales of its COVID-19 vaccine, even with low revenue from its new respiratory syncytial virus shot. The Cambridge, Massachusetts-based company posted a profit of $13 million, or 3 cents a…